Capra hircus (goat): 102177031
Help
Entry
102177031 CDS
T02910
Symbol
CASP3
Name
(RefSeq) caspase-3
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
chx
Capra hircus (goat)
Pathway
chx01524
Platinum drug resistance
chx04010
MAPK signaling pathway
chx04115
p53 signaling pathway
chx04148
Efferocytosis
chx04210
Apoptosis
chx04215
Apoptosis - multiple species
chx04623
Cytosolic DNA-sensing pathway
chx04650
Natural killer cell mediated cytotoxicity
chx04657
IL-17 signaling pathway
chx04668
TNF signaling pathway
chx04726
Serotonergic synapse
chx04932
Non-alcoholic fatty liver disease
chx04933
AGE-RAGE signaling pathway in diabetic complications
chx04936
Alcoholic liver disease
chx05010
Alzheimer disease
chx05012
Parkinson disease
chx05014
Amyotrophic lateral sclerosis
chx05016
Huntington disease
chx05020
Prion disease
chx05022
Pathways of neurodegeneration - multiple diseases
chx05132
Salmonella infection
chx05133
Pertussis
chx05134
Legionellosis
chx05145
Toxoplasmosis
chx05146
Amoebiasis
chx05152
Tuberculosis
chx05160
Hepatitis C
chx05161
Hepatitis B
chx05162
Measles
chx05163
Human cytomegalovirus infection
chx05164
Influenza A
chx05165
Human papillomavirus infection
chx05167
Kaposi sarcoma-associated herpesvirus infection
chx05168
Herpes simplex virus 1 infection
chx05169
Epstein-Barr virus infection
chx05170
Human immunodeficiency virus 1 infection
chx05200
Pathways in cancer
chx05203
Viral carcinogenesis
chx05205
Proteoglycans in cancer
chx05206
MicroRNAs in cancer
chx05210
Colorectal cancer
chx05222
Small cell lung cancer
chx05416
Viral myocarditis
chx05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
chx00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
102177031 (CASP3)
04668 TNF signaling pathway
102177031 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
102177031 (CASP3)
09143 Cell growth and death
04210 Apoptosis
102177031 (CASP3)
04215 Apoptosis - multiple species
102177031 (CASP3)
04115 p53 signaling pathway
102177031 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
102177031 (CASP3)
04650 Natural killer cell mediated cytotoxicity
102177031 (CASP3)
04657 IL-17 signaling pathway
102177031 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
102177031 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
102177031 (CASP3)
05206 MicroRNAs in cancer
102177031 (CASP3)
05205 Proteoglycans in cancer
102177031 (CASP3)
05203 Viral carcinogenesis
102177031 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
102177031 (CASP3)
05222 Small cell lung cancer
102177031 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
102177031 (CASP3)
05161 Hepatitis B
102177031 (CASP3)
05160 Hepatitis C
102177031 (CASP3)
05164 Influenza A
102177031 (CASP3)
05162 Measles
102177031 (CASP3)
05168 Herpes simplex virus 1 infection
102177031 (CASP3)
05163 Human cytomegalovirus infection
102177031 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
102177031 (CASP3)
05169 Epstein-Barr virus infection
102177031 (CASP3)
05165 Human papillomavirus infection
102177031 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
102177031 (CASP3)
05133 Pertussis
102177031 (CASP3)
05134 Legionellosis
102177031 (CASP3)
05152 Tuberculosis
102177031 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
102177031 (CASP3)
05145 Toxoplasmosis
102177031 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
102177031 (CASP3)
05012 Parkinson disease
102177031 (CASP3)
05014 Amyotrophic lateral sclerosis
102177031 (CASP3)
05016 Huntington disease
102177031 (CASP3)
05020 Prion disease
102177031 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
102177031 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
102177031 (CASP3)
05416 Viral myocarditis
102177031 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
102177031 (CASP3)
04932 Non-alcoholic fatty liver disease
102177031 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
102177031 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
102177031 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
chx01002
]
102177031 (CASP3)
Enzymes [BR:
chx01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
102177031 (CASP3)
Peptidases and inhibitors [BR:
chx01002
]
Cysteine peptidases
Family C14: caspase family
102177031 (CASP3)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
Peptidase_C14
Motif
Other DBs
NCBI-GeneID:
102177031
NCBI-ProteinID:
NP_001273018
UniProt:
H9B8T7
LinkDB
All DBs
Position
27:30490189..30513137
Genome browser
AA seq
275 aa
AA seq
DB search
MENTENSVDSKSIKTSETTILHGSKSVDSGISLEESYKMDYPEMGLCIIINNKNFHENTG
MACRSGTDVDAANLRETFTSLKYEVRIKNDLTRKEMLELMSDVSKEDHSKRSSFICVLLS
HGEEGIIFGTNGPVDLKKLASFFRGDCCRSLTGKPKLFIIQACRGTDLDCGIETDSGSED
DMACQKIPVEADFLYAYSTAPGYFSWRNSKYGSWFIQALCEMLKKYAHKLELMHILTRVN
RKVATEYESFSTDSAFHAKKQIPCIMSMLTKELYF
NT seq
828 nt
NT seq
+upstream
nt +downstream
nt
atggagaacactgaaaattcagtggattcaaaatccattaaaacttcagagacaacgatc
ttacacggaagcaaatcagtggactccggaatatccttggaagagagttacaaaatggat
tatcctgaaatgggtttatgtataataattaataataagaacttccacgaaaatactggc
atggcctgtcgatctggtacagacgtggatgcagcaaacctcagggaaaccttcacgagc
ttgaaatatgaagtcaggattaaaaacgatcttacacgtaaagaaatgttggaattaatg
agcgacgtttctaaggaagaccatagcaaaaggagcagttttatttgcgtgcttctaagc
catggtgaagaaggaatcatttttggaaccaatggacccgtcgatctgaaaaaattagca
agtttcttcagaggggactgttgcagaagtctgactggaaaacccaaacttttcattatt
caggcctgccgaggcacagacctggactgtggtattgagacagacagtggttctgaggac
gacatggcctgtcagaaaataccagttgaggcagacttcttgtacgcatattctacagca
cctggttacttttcctggcgaaactcaaagtacggatcctggttcatccaggctctttgt
gagatgctgaaaaagtacgctcacaagctcgagctcatgcacattcttactcgggttaac
cgaaaggtagcgacagaatatgagtccttttccaccgattctgcttttcatgcaaagaaa
cagattccttgtatcatgtctatgctcacaaaagaactgtatttctaa
DBGET
integrated database retrieval system